Main Content

The Missouri University of Science and Technology Institutional Biosafety Committee (IBC) is charged by federal law to review and approve elements of a campus biosafety program. The purpose of this program is to ensure the health and safety of all personnel working with biohazardous materials. The biohazardous materials include synthetic or recombinant nucleic acids, microbial vectors that spread infectious diseases, and federal select agents.

The federal regulations and guidelines include the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, NIH Guidelines, the Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition, and the Federal Select Agents Regulations. These form the basis for campus biosafety policies and procedures and reviewing individual research proposals for biosafety concerns.

The IBC consists of members with expertise and research experience in biohazardous materials and biosafety experiments that may pose potential risks to health or the environment. The committee is composed of one toxicologist, one plant biologist, one microbiologist, one stem cell biologist, one biological safety officer, the director of the S&T Department of Environmental Health and Safety, and two Rolla citizens who are not affiliated with S&T.

Any S&T personnel who plan to conduct research, no matter whether funded or not, involving federally regulated biohazardous materials are required to apply to the S&T IBC for approval. The required documents are listed on this website. Any questions in the context of the application should be addressed to Anna Chernatynskaya, Chair of the IBC.

S&T IBC Weblinks and Documentation:

S&T IBC Protocol Checklist  -  protocol submission checklist

S&T IBC Registration Document  -  registration template to be filled out

S&T IBC Training Program  -  CITI training

S&T IBC Containment Determination  -  containment level flowchart

S&T Safety Guidelines for Using Nanoparticles

Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition - PDF version

 

Anna Chernatynskaya, MS

Research Project Analyst Lead Chair of the IBC

Compliance Policy Overview

Compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules is mandatory for all institutions receiving NIH funding for recombinant DNA (rDNA) research. Principal Investigators (PIs) are ultimately responsible for ensuring their laboratories remain fully compliant.

Official NIH reference links:

Note: Please consult the official NIH links above for the most up-to-date regulations.

NIH Guidelines